- Oxford coronavirus vaccine shows strong immune response in early trialCBS News
- Coronavirus vaccine from Oxford and AstraZeneca shows positive response in early trialCNBC
- Coronavirus: Oxford/AstraZeneca Phase 1/2 trial shows safe, immunogenic vaccine, S&P 500 positiveFXStreet
- Oxford coronavirus vaccine induces strong immune response, early trial results suggestNBC News
- AstraZeneca’s shares are up 0.1% as investors prepare for vaccine dataMarketWatch
- View Full Coverage on Google News